Skip to main content

Table 2 Potential large animal application with DUS-targeted gene delivery

From: Utilization of diagnostic ultrasound and intravenous lipid-encapsulated perfluorocarbons in non-invasive targeted cardiovascular therapeutics

Disease entity DUS frequency/trigging Specific gene Specific application
Diabetes 1:4 DNA-planned Beta cell regeneration
Limb ischemia 1:4 DNA-planned VGE Angiogenesis
Tumor   DNA Tumor suppression
Tumor 1:10 ShRNA Anti-angiogenesis